Fruquintinib Renal Impairment Study

NCT05216354 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: Fruquintinib

Sponsor

Hutchmed